<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCT</journal-id><journal-title-group><journal-title>Journal of Cancer Therapy</journal-title></journal-title-group><issn pub-type="epub">2151-1934</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jct.2018.93022</article-id><article-id pub-id-type="publisher-id">JCT-83012</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Comparing Nasal Cavity Radiotherapy Using Electron, Photon, Proton and Photon-Electron Beams
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Navid</surname><given-names>Khaledi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Foad</surname><given-names>Goli Ahmadabad</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Susan</surname><given-names>Ebam</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Roghiye</surname><given-names>Bodaghi Hosseinabadi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Environmental Health engineering, Jiroft university of Medical Sciences, Jiroft, Iran</addr-line></aff><aff id="aff2"><addr-line>School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran</addr-line></aff><aff id="aff4"><addr-line>Department of Environmental Health, Khoy University of Medical Science, Khoy, Iran</addr-line></aff><aff id="aff1"><addr-line>Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>khaledi@sbmu.ac.ir(FGA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>03</month><year>2018</year></pub-date><volume>09</volume><issue>03</issue><fpage>255</fpage><lpage>261</lpage><history><date date-type="received"><day>19,</day>	<month>October</month>	<year>2017</year></date><date date-type="rev-recd"><day>11,</day>	<month>March</month>	<year>2018</year>	</date><date date-type="accepted"><day>14,</day>	<month>March</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Aim:
   Electron, photon or proton beams are used in radiotherapy for cancer treatment while each one may be used depending on depth and the location of tumor and normal tissues around the treatment target as well as economic issues. <b>Materials and Methods:</b> In this research, dose distribution by proton was measured by film dosimetry in nasal cavity Plexiglas phantom and Monte Carlo simulation. Then the DVH of treatment target and the posterior of treatment target of different beams were compared. The energies of electron, photon and proton were 9 MeV, 6 MV, and maximum 65 MeV, respectively. Due to a depth of 3.5 cm of CTV (Clinical Target Volume), Modulation Range was between 0
   
  -
   
  3.5 cm and SOBP (Spread-out Bragg Peak) was between 0
   
  -
   
  65 MeV. <b>Results:</b> Comparing the obtained DVH values, 95% dose coverage of target volume for electron, photon, proton and Photon-Electron beams were 88%, 98%, 98%, and 95%, respectively. However, doses above 40% that reached outside the target were 50%, 82%, 5%, and 44%, respectively. <b>Conclusions:</b> The results demonstrate the superiority of proton therapy in nasal cancer due to its better target volume coverage and the less amount of the dose reaching outside the target that is because of dose discharge in a small area and significant dose fall-off after Bragg peak.
 
</p></abstract><kwd-group><kwd>Electron</kwd><kwd> Photon</kwd><kwd> Proton</kwd><kwd> Mixed Beam</kwd><kwd> Monte Carlo</kwd><kwd> Film Dosimetry</kwd><kwd> Nasal Cavity Cancer</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Depending on the position and depth of a tumor, electron, photon, mixed electron-photon, or proton beams may be used in radiation therapy. For shallow-seated lesions, in this study nasal-cavity lesions, the most common method for treatment is using electron beam, because of its low penetration depth and therefore sparing the beyond organs from receiving the radiation dose.</p><p>Some investigation has been performed about comparison of mixed electron-photon beam and conventional methods [<xref ref-type="bibr" rid="scirp.83012-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.83012-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.83012-ref3">3</xref>] . These studies showed that the mixed beam has some advantages over electron or photon beams. For example, the electron beam is more sensitive to small fields [<xref ref-type="bibr" rid="scirp.83012-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.83012-ref5">5</xref>] than mixed or photon beams.</p><p>Xiong et al. conducted a research to optimize dose distribution of photon and electron combination in breast [<xref ref-type="bibr" rid="scirp.83012-ref6">6</xref>] . They compared three techniques that one of these techniques was the combination of photon IMRT and electron IMRT. Their research showed that a combination of photons and electrons reduces the lack of uniformity in the target significantly. In another study, a comparison between combination of IMRT and conformal electron treatment method along with a bolus for parotid and chest areas had been made in a polyethylene phantom by film dosimetry with a 4%/2 mm criteria gamma index [<xref ref-type="bibr" rid="scirp.83012-ref7">7</xref>] . They used electron energies of 16 and 20 MeV. Consequently, in a combination of 2:1 of electron: photon mixture, a more uniform dose coverage than the pure electron in the chest and parotid area was observed. In addition, coincidence between the pure electron and the mixed field for the parotid and chest was 95.9% - 98.8%.</p><p>In another investigation, a comparison was done between Helical Tomotherapy and mixed beam for Glioblastoma Multiforme (GBM) brain tumors [<xref ref-type="bibr" rid="scirp.83012-ref8">8</xref>] . In here, 20 plans were compared for GBM. Both types of plans in terms of homogeneity index, conformity index, and the dose reached to healthy tissues were compared that the results were similar for the mixed beam and Helical Tomotherapy. Only when a normal tissue was very close to the therapeutic target, the Helical Tomotherapy was able to do a better protection on the normal tissue.</p><p>A series of studies have been done on the advantages of proton beam in treatment of nasal, para-nasal and sinus lesions [<xref ref-type="bibr" rid="scirp.83012-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.83012-ref13">13</xref>] . The proton therapy (PT) delivered a lower mean dose to desired normal tissues in comparison with the IMRT [<xref ref-type="bibr" rid="scirp.83012-ref10">10</xref>] . In addition, the local control for the PT was better than conventional methods after over 3 years and it showed significantly higher disease-free survival at 5 years [<xref ref-type="bibr" rid="scirp.83012-ref11">11</xref>] .</p><p>There is no study regarding the comparison of the mentioned different beams. Therefore, because of novelty of mixed electron-photon beam in recent researches [<xref ref-type="bibr" rid="scirp.83012-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.83012-ref14">14</xref>] and PT in modern radiotherapy centers, the present study can be useful for comparison of such beams. By this way, a Monte Carlo (MC) simulation of dose distribution in a Perspex nasal phantom by PT has been compared with dose distribution by MC calculation and film dosimetry of electron, photon, and mixed beam.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>Dose distributions (Isodoses) measurement in a heterogeneous region was performed by a high dose range (EDR2) Kodak (Rochester, New York) film in a Plexiglas Phantom. The Perspex phantom was used for dosimetry because of its density (1.06 gr/cm<sup>3</sup>) that is close to soft tissue. Film dosimetry in this Plexiglas phantom allows us to estimate the dose distribution of the mixed photons and electrons beam as well as the pure photon or electron inside the phantom, especially in the heterogeneous areas (nasal and sinus). The Plexiglas phantom was built of twenty slices with thickness of 1 cm.</p><p>Because of the specialty of the treatment planning systems algorithms to calculate the dose distribution in material for cases merely photon or merely electron, the MC codes can be a good option for calculation of dose distribution.</p><p>A Varian 2300 CD linear accelerator was used in this study as a source of the photon or electron beams. The dose rate in this linac is 300 MU/Min in normal mode that can be increased to 1000 MU/Min. The distance of applicator tray to source is 63 cm. The length of applicator is also 32 cm; it means the applicator end distance to Isocenter is 5 cm.</p><p>A clinical tumor volume (CTV) with dimensions 3 &#215; 3.5 cm<sup>2</sup> was considered in the nasal cavity of the phantom (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The irradiation was performed by placing each film among the middle slice of phantom (ten slices from each side) and the SSD was 100 cm. Film dosimetry was conducted for 9 MeV electron beam and photon beam of 6 MV and one mode of the mixed beam (20/80 ratio of photon to electron mixture).</p><p>In order to calibrate the optical density (OD) and to obtain the film dosimetry calibration curve, each calibration films were placed in water-equivalent sheets of RW3 (PTW, Freiburg) with density of 1.05 gr/cm<sup>3</sup>. The thickness of each sheets were 1 cm. In this case, films were placed perpendicular to the beam's central axis.</p><p>After designing and introducing geometrical features of linac, including collimator, primary and secondary scattering foil and applicator as well as lead and steel shielding and also water phantom and Plexiglas phantom in AutoCAD software, the MC simulation was started. The applied MC code was MCNPX v2.6 [<xref ref-type="bibr" rid="scirp.83012-ref15">15</xref>] . The library used to transport photon was MCLIB04, and EL03 was also used for electron. In addition, the cut-off energies for electron and photon were chosen 0.5 and 0.03 MeV, respectively. Importance of all materials (cells) in the simulation was selected equal to unit (IMP = 1).</p><p>To obtain the beam quality and distribution of the electron beam exited from Bending Magnet in MC, the PDD and profile in a water phantom should be measured. As a result, by changing the energy FWHM, peak energy, spatial FWHM, and its angular distribution, the measured and simulated PDDs and profiles matched on each other. The most important parameters of conformity of measurement and simulation electron PDDs are the depth of 50% dose (R<sub>50</sub>) and the practical range (R<sub>P</sub>).</p><p>For isodose simulation of proton beam, two wax wedges placed at the path of the protons as compensators, compensating the shape of nose (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The Spread-out Bragg Peak (SOBP) was between 0 - 65 MeV with a modulation</p><p>range of 0 - 3.5 cm. Moreover, the proton source distribution was a 3.2 &#215; 3.2 cm<sup>2</sup> square (0.2 cm wider than CTV size for penumbra consideration), placed 30 cm above the nasal phantom.</p></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows the obtained calibration curve for film dosimetry used in the Verisoft software. This calibration curve used for all measured dose distributions in film dosimetry.</p><p>The area of nasal region and Ethmoid sinus were divided to 2 &#215; 2 cm<sup>2</sup> segments, by calculation of the delivered dose to each of these segments dose-surface-histogram was obtained. By extracting the DSH data, the coverage of CTV by isodose of 95%, as well as, the delivered doses higher than 40% of prescribed dose to the normal tissues outside of the CTV showed in <xref ref-type="table" rid="table1">Table 1</xref>. As can be seen from this table, the best coverage of CTV is for 6 MV photon and 0 - 65 MeV protons, but, the maximum doses to the normal tissues irradiated by 6 MV photon (82%).</p><p>By comparing the results in <xref ref-type="table" rid="table1">Table 1</xref>, it is clear that the balance between CTV coverage and dose delivery to normal tissues belongs to proton beam (5%). Next, the mixed beam with 44% dose to normal tissues shows the second good result.</p><p>The isodose color-wash for nasal cavity in proton therapy mode is illustrated in <xref ref-type="fig" rid="fig3">Figure 3</xref>. In this figure the good coverage of CTV and low isodose levels in the outside of the CTV, obviously visible. In here, the coverage of 100% isodose in nasal cavity and 10% isodose reached to OARs are more tangible than other techniques.</p></sec><sec id="s4"><title>4. Discussion</title><p>Due to the sensitivity of electron beam to heterogeneity and the shape of irradiated medium, the dose coverage between the nasal holes, with 55% isodose,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The CTV coverage of 95% isodose and the delivered doses above 40% to the Normal tissues beyond the CTV</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Beam type</th><th align="center" valign="middle" >CTV coverage (%)</th><th align="center" valign="middle" >Delivered dose to normal tissues (%)</th></tr></thead><tr><td align="center" valign="middle" >9 MeV electron beam</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >6 MV photon beam</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >82</td></tr><tr><td align="center" valign="middle" >Mixed beam</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >44</td></tr><tr><td align="center" valign="middle" >Proton beam</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >5</td></tr></tbody></table></table-wrap><p>was very poor. For the photon beam, due to the low gradient of dose fall-off, nevertheless the good coverage of CTV area, the high level dose was present in the outside of the CTV.</p><p>However, the sparing of outside of the treatment target, in the mixed beam mode was better than both of electron and photon beams. It showed a better nasal cavity and nasal septum coverage in comparison with the electron beam, as well as better OAR sparing compared with photons. In the proton state, both coverage of nasal cavity and nasal septum was far better than other techniques. In addition, the homogeneity index in the CTV for PT was 11%, 18%, 31% better than, mixed beam, photons, and electrons, respectively.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study showed that the excellent coverage of treatment target and sparing the normal tissues by proton beam is in comparison with the other methods. The low amount of doses outside of the target, was very considerable. After this beam, the mixed electron-photon beam had the next stage between the investigated beams. This study, parallel with literature, demonstrate the significant capability of PT for cancer treatment, especially in the nasal case that the high amount of delivered dose arisen from the SOBP tail in the single field is not matter. But the economic issues in application of proton beam could not be neglected, because this type of treatment is very expensive than other mentioned methods.</p></sec><sec id="s6"><title>Cite this paper</title><p>Khaledi, N., Ahmadabad, F.G., Ebam, S. and Hosseinabadi, R.B. (2018) Comparing Nasal Cavity Radiotherapy Using Electron, Photon, Proton and Photon-Electron Beams. Journal of Cancer Therapy, 9, 255-261. https://doi.org/10.4236/jct.2018.93022</p></sec></body><back><ref-list><title>References</title><ref id="scirp.83012-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Blasi, O., Fontenot, J.D., Fields, R.S., Gibbons, J.P. and Hogstrom, K.R. (2011) Preliminary Comparison of Helical Tomotherapy and Mixed Beams of Unmodulated Electrons and Intensity Modulated Radiation Therapy for Treating Superficial Cancers of the Parotid Gland and Nasal Cavity. Radiation Oncology, 6, 178. 
https://doi.org/10.1186/1748-717X-6-178</mixed-citation></ref><ref id="scirp.83012-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Khaledi, N., Arbabi, A., Sardari, D., Mohammadi, M. and Ameri, A. (2015) Simultaneous Production of Mixed Electron-Photon Beam in a Medical LINAC: A Feasibility Study. Physica Medica, 31, 391-397.  
https://doi.org/10.1016/j.ejmp.2015.02.014</mixed-citation></ref><ref id="scirp.83012-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mu, X., Olofsson, L., Karlsson, M., Sjogren, R. and Zackrisson, B. (2004) Can Photon IMRT Be Improved by Combination with Mixed Electron and Photon Techniques? Acta Oncologica, 43, 727-735. https://doi.org/10.1080/02841860410002761</mixed-citation></ref><ref id="scirp.83012-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Khaledi, N., Arbabi, A., Sardari, D., Mahdavi, S.R., Aslian, H., Dabaghi, M. and Sheibani, K. (2013) Monte Carlo Investigation of the Effect of Small Cutouts on Beam Profile Parameters of 12 and 14 MeV Electron Beams. Radiation Measurements, 51-52, 48-54. https://doi.org/10.1016/j.radmeas.2013.01.019</mixed-citation></ref><ref id="scirp.83012-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Khaledy, N., Arbabi, A. and Sardari, D. (2011) The Effects of Cutouts on Output, Mean Energy and Percentage Depth Dose of 12 and 14 MeV Electrons. Journal of Medical Physics, 36, 213-219. https://doi.org/10.4103/0971-6203.89970</mixed-citation></ref><ref id="scirp.83012-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Xiong, W., Li, J., Chen, L., Price, R., Freedman, G., Ding, M. and Ma, C. (2004) Optimization of Combined Electron and Photon Beams for Breast Cancer. Physics in Medicine &amp; Biology, 49, 1973-1989. https://doi.org/10.1088/0031-9155/49/10/010</mixed-citation></ref><ref id="scirp.83012-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kavanaugh, J.A., Hogstrom, K.R., Chu, C., Carver, R.A., Fontenot, J.P. and Henkelmann, G. (2013) Delivery Confirmation of Bolus Electron Conformal Therapy Combined with Intensity Modulated X-Ray Therapy. Medical Physics, 40, 21-28.  
https://doi.org/10.1118/1.4788657</mixed-citation></ref><ref id="scirp.83012-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Koca, T., Basaran, H., Sezen, D., Karaca, S., Ors, Y., Arslan, D. and Aydin, A. (2014) Comparison of Linear Accelerator and Helical Tomotherapy Plans for Glioblastoma Multiforme Patients. Asian Pacific Journal of Cancer Prevention: Asian Pacific Journal of Cancer Prevention, 15, 7811-7816.  
https://doi.org/10.7314/APJCP.2014.15.18.7811</mixed-citation></ref><ref id="scirp.83012-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Fukumitsu, N., Ishikawa, H., Ohnishi, K., Terunuma, T., Mizumoto, M., Numajiri, H. and Sakae, T. (2014) Dose Distribution Resulting from Changes in Aeration of Nasal Cavity or Paranasal Sinus Cancer in the Proton Therapy. Radiotherapy and oncology, 113, 72-76. https://doi.org/10.1016/j.radonc.2014.08.024</mixed-citation></ref><ref id="scirp.83012-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">McDonald, M.W., Liu, Y., Moore, M.G. and Johnstone, P.A. (2016) Acute Toxicity in Comprehensive Head and Neck Radiation for Nasopharynx and Paranasal Sinus Cancers: Cohort Comparison of 3D Conformal Proton Therapy and Intensity Modulated Radiation Therapy. Radiation Oncology, 11, 32.  
https://doi.org/10.1186/s13014-016-0600-3</mixed-citation></ref><ref id="scirp.83012-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Patel, S.H., Wang, Z., Wong, W.W., Murad, M.H., Buckey, C.R., Mohammed, K. and Schild, S.E. (2014) Charged Particle Therapy versus Photon Therapy for Paranasal Sinus and Nasal Cavity Malignant Diseases: A Systematic Review and Meta-Analysis. The Lancet Oncology, 15, 1027-1038.  
https://doi.org/10.1016/S1470-2045(14)70268-2</mixed-citation></ref><ref id="scirp.83012-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Zenda, S., Akimoto, T., Mizumoto, M., Hayashi, R., Arahira, S., Okumura, T. and Sakurai, H. (2016) Phase II Study of Proton Beam Therapy as a Nonsurgical Approach for Mucosal Melanoma of the Nasal Cavity or Para-Nasal Sinuses. Radiotherapy and Oncology, 118, 267-271. https://doi.org/10.1016/j.radonc.2015.10.025</mixed-citation></ref><ref id="scirp.83012-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Zenda, S., Kawashima, M., Arahira, S., Kohno, R., Nishio, T., Tahara, M. and Akimoto, T. (2015) Late Toxicity of Proton Beam Therapy for Patients with the Nasal cavity, Para-Nasal Sinuses, or Involving the Skull Base Malignancy: Importance of Long-Term Follow-Up. International Journal of Clinical Oncology, 20, 447-454.  
https://doi.org/10.1007/s10147-014-0737-8</mixed-citation></ref><ref id="scirp.83012-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Khaledi, N., Sardari, D., Mohammadi, M., Ameri, A. and Reynaert, N. (2018) Dosimetric Evaluation of a Novel Electron-Photon Mixed Beam, Produced by a Medical Linear Accelerator. Journal of Radiotherapy in Practice, 1-13. 
https://doi.org/10.1017/S1460396917000711</mixed-citation></ref><ref id="scirp.83012-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Briesmeister, J.F. (1986) MCNP—A General Monte Carlo Code for Neutron and Photon Transport-Version 3A: Los Alamos National Laboratory Report LA-7396-M.</mixed-citation></ref></ref-list></back></article>